August 30, 2016 10:04 PM ET

Pharmaceuticals

Company Overview of Nabriva Therapeutics AG

Executive Profile

George Harrison Talbot M.D.

Member of the Supervisory Board, Nabriva Therapeutics AG
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 4 different industries.

See Board Relationships
68€323,000

Background

Dr. George Harrison Talbot, M.D., founded Talbot Advisors LLC in 2000. Dr. Talbot provides consultative services to the pharmaceutical industry and venture capital groups through Talbot Advisors. He served as Chief Medical Officer and Executive Vice President of Cerexa, Inc. from July 28, 2006 to October 2007. Dr. Talbot is an accomplished infectious diseases specialist with more than 25 years of pharmaceutical industry and medical experience and played a key strategic ...

Corporate Headquarters

Leberstrasse 20
Vienna, Vienna 1110

Austria

Phone: 43 1 740 93 0
Fax: 43 1 740 93 1900

Board Members Memberships

There is no Board Members Memberships data available.

Education

BA
Wesleyan University
Doctorate
Yale University School Of Medicine

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation€323,000
Total Calculated Compensation€323,000
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Nabriva Therapeutics AG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.